Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filorexant in Painful Diabetic Neuropathy
NCT01564459Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of filorexant in diabetic neuropathy, sponsored by Merck & Co.. Started Mar 2012; status: completed.
02
Drugs
filorexant
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01564459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01564459.